F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
21.17M
Cost of Revenue
n/a
Gross Profit
21.17M
Operating Income
-30.71M
Interest Income
n/a
Pretax Income
-31.66M
Net Income
-31.28M
Selling & General & Admin
23.13M
Research & Development
28.75M
Other Expenses
n/a
Operating Expenses
51.88M
Interest Expense
844K
Selling & Marketing Expenses
n/a
Cost & Expenses
51.88M
Income Tax Expense
-372K
Shares Outstanding (Basic)
16.65M
Shares Outstanding (Diluted)
16.65M
EPS (Basic)
-1.88
EPS (Diluted)
-1.88
EBITDA
-29.42M
EBIT
-30.81M
Depreciation & Amortization
1.29M